PT3157930T - Métodos para a preparação de compostos heterocíclicos de 1,3-benzodioxole - Google Patents

Métodos para a preparação de compostos heterocíclicos de 1,3-benzodioxole

Info

Publication number
PT3157930T
PT3157930T PT15730183T PT15730183T PT3157930T PT 3157930 T PT3157930 T PT 3157930T PT 15730183 T PT15730183 T PT 15730183T PT 15730183 T PT15730183 T PT 15730183T PT 3157930 T PT3157930 T PT 3157930T
Authority
PT
Portugal
Prior art keywords
preparation
methods
heterocyclic compounds
benzodioxole
benzodioxole heterocyclic
Prior art date
Application number
PT15730183T
Other languages
English (en)
Portuguese (pt)
Inventor
Metzler Bjorn
Faldt André
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of PT3157930T publication Critical patent/PT3157930T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
PT15730183T 2014-06-23 2015-06-22 Métodos para a preparação de compostos heterocíclicos de 1,3-benzodioxole PT3157930T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14173397 2014-06-23

Publications (1)

Publication Number Publication Date
PT3157930T true PT3157930T (pt) 2018-12-24

Family

ID=50980952

Family Applications (1)

Application Number Title Priority Date Filing Date
PT15730183T PT3157930T (pt) 2014-06-23 2015-06-22 Métodos para a preparação de compostos heterocíclicos de 1,3-benzodioxole

Country Status (18)

Country Link
US (1) US9908894B2 (enExample)
EP (1) EP3157930B1 (enExample)
JP (1) JP6785666B2 (enExample)
KR (1) KR20170016894A (enExample)
CN (1) CN106459081B (enExample)
AU (1) AU2015279428B2 (enExample)
BR (1) BR112016029510A2 (enExample)
CA (1) CA2953284A1 (enExample)
DK (1) DK3157930T3 (enExample)
ES (1) ES2702451T3 (enExample)
IL (1) IL249336A0 (enExample)
MX (1) MX2016016378A (enExample)
PL (1) PL3157930T3 (enExample)
PT (1) PT3157930T (enExample)
RU (1) RU2697251C2 (enExample)
TW (1) TW201613934A (enExample)
WO (1) WO2015197534A2 (enExample)
ZA (1) ZA201608442B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX385592B (es) * 2015-12-18 2025-03-18 Union Therapeutics As Metodos para preparacion de compuestos heterociclicos de 1,3-benzodioxol.
CA3064033A1 (en) * 2017-06-20 2018-12-27 Leo Pharma A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
DK3724196T3 (da) 2017-12-15 2023-01-16 Union Therapeutics As Substituerede azetidindihydrothienopyridiner og anvendelse deraf som phosphodiesterasehæmmere
USD914676S1 (en) 2018-05-11 2021-03-30 Samsung Electronics Co., Ltd. Notebook computer
NZ778223A (en) 2019-01-15 2024-11-29 Union Therapeutics As Modified release tablet formulations containing phosphodiesterase inhibitors
AU2022245186A1 (en) 2021-03-22 2023-10-05 UNION therapeutics A/S Treatment of hidradenitis suppurativa with orismilast
GB202205715D0 (en) 2022-04-19 2022-06-01 Union Therapeutics As Treatment of neutrophilic dermatoses
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
ATE325110T1 (de) * 1995-05-19 2006-06-15 Kyowa Hakko Kogyo Kk Sauerstoff enthaltende heterocyclische verbindungen
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
JPWO2004005276A1 (ja) * 2002-07-03 2005-11-04 協和醗酵工業株式会社 1,3−ベンゾジオキソール−2−スピロシクロアルカン誘導体の製造法
ATE496029T1 (de) * 2006-07-14 2011-02-15 Chiesi Farma Spa Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
DK2125736T3 (da) * 2006-12-22 2011-07-11 Leo Pharma As Substituerede acetophenoner egnede som PDE4-inhibitorer
PL2114951T3 (pl) * 2007-02-28 2014-10-31 Leo Pharma As Nowe inhibitory fosfodiesterazy
ZA200905371B (en) * 2007-02-28 2010-10-27 Leo Pharma As Novel phosphodiesterase Inhibitors
ES2733092T3 (es) * 2010-06-24 2019-11-27 Leo Pharma As Derivados de benzodioxol como inhibidores de la fosfodiesterasa
WO2014096018A1 (en) * 2012-12-19 2014-06-26 Leo Pharma A/S Methods for the preparation of substituted acetophenones
MX385592B (es) * 2015-12-18 2025-03-18 Union Therapeutics As Metodos para preparacion de compuestos heterociclicos de 1,3-benzodioxol.

Also Published As

Publication number Publication date
ES2702451T3 (es) 2019-03-01
JP2017520547A (ja) 2017-07-27
BR112016029510A2 (pt) 2017-08-22
WO2015197534A2 (en) 2015-12-30
MX2016016378A (es) 2017-10-16
IL249336A0 (en) 2017-02-28
AU2015279428A1 (en) 2017-01-05
PL3157930T3 (pl) 2019-04-30
TW201613934A (en) 2016-04-16
RU2017101808A3 (enExample) 2019-01-22
EP3157930B1 (en) 2018-10-17
RU2017101808A (ru) 2018-07-27
EP3157930A2 (en) 2017-04-26
DK3157930T3 (en) 2019-01-21
AU2015279428B2 (en) 2018-02-15
CN106459081A (zh) 2017-02-22
US9908894B2 (en) 2018-03-06
ZA201608442B (en) 2018-05-30
RU2697251C2 (ru) 2019-08-13
KR20170016894A (ko) 2017-02-14
WO2015197534A3 (en) 2016-03-17
CA2953284A1 (en) 2015-12-30
JP6785666B2 (ja) 2020-11-18
CN106459081B (zh) 2019-09-10
US20170137438A1 (en) 2017-05-18

Similar Documents

Publication Publication Date Title
ZA201605622B (en) 1,3-benzodioxole derivative
AP2016009297A0 (en) Novel heterocyclic compounds
IL247018A0 (en) Heterocyclic compound
IL248991A0 (en) Converted dihydroisoquinolinone compounds
ZA201700019B (en) Substituted [1,2,4]triazole compounds
IL285105A (en) Heterocyclic compound
IL259617B (en) Methods for the preparation of 3,1-benzodioxole heterocyclic compounds
IL271399A (en) Methods for the preparation of heterocyclic 3,1-benzodioxole compounds
ZA201608442B (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
EP3110819A4 (en) Heterocyclic compounds
IL248267B (en) A process for preparing converted cycloserines
HUE036789T2 (hu) Szintéziseljárás 1,2-benzizotiazolin-3-on elõállítására
IL259556A (en) Solid forms of substituted 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine compounds
PT3159335T (pt) Novo composto heterocíclico
IL260070B (en) A method for the preparation of converted 2-aryl-ethanols
GB2564185B (en) Process for the preparation of derivatives of benzodioxole
GB201501696D0 (en) Pharamaceutical Compounds
SG10201402964RA (en) Dehydration of 2,3-butanediole
GB201408238D0 (en) Synthesis of substituted 1,2,3-Triazoles